Tea: A native source of antimicrobial agents

Food Research International

Volumn 53, Issue 2, 2013, Pages 568-584

  Bansal, Sumit ^a   Choudhary, Shivani ^b   Sharma, Manu ^a   Kumar, Suthar Sharad ^a   Lohan, Sandeep ^a   Bhardwaj, Varun ^a   Syan, Navneet ^c   Jyoti, Saras ^a  

^a JAYPEE UNIVERSITY OF INFORMATION TECHNOLOGY   (India)

^b MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES   (India)

^c Ganpati Institute of Pharmacy   (India)

Author keywords

Antibiotic; Camellia sinensis; Epigallocatechin 3 gallate; MRSA; Polyphenols; Synergism

Indexed keywords

CAMELLIA SINENSIS; EPIGALLOCATECHIN-3-GALLATE; MRSA; POLYPHENOLS; SYNERGISM;

ANTIBIOTICS; MICROORGANISMS;

ANTIMICROBIAL AGENTS;

CAMELLIA SINENSIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;

EID: 84882810764     PISSN: 09639969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.foodres.2013.01.032     Document Type: Review

References (161)

1. Abd A.A.A., Ibrahium M.I., Al-Atrouny A.M. Effect of black tea on some cariogenic bacteria. World Applied Sciences Journal 2011, 12:552-558.
2. Almajano M.P., Carbó R., Jiménez J.A.L., Gordon M.H. Antioxidant and antimicrobial activities of tea infusions. Food Chemistry 2008, 108:55-63.
3. Anand P.K., Kaul D., Sharma M. Green tea polyphenol inhibits Mycobacterium tuberculosis survival within human macrophages. The International Journal of Biochemistry & Cell Biology 2006, 38:600-609.
4. Ankolekar C., Johnson D., Pinto M.D.S., Johnson K., Labbe R., Shetty K. Inhibitory potential of tea polyphenolics and influence of extraction time against Helicobacter pylori and lack of inhibition of beneficial lactic acid bacteria. Journal of Medicinal Food 2011, 14:1321-1329.
5. Apostolides, Z. & Selematsela, M. (2003). Anti-retroviral agent in combination with tea polyphenol for the treatment of viral infections. PCT International Application, WO 2003002126 A1 20030109.
6. Arakawa H., Maeda M., Okubo S., Shimamura T. Role of hydrogen peroxide in bactericidal action of catechin. Biological & Pharmaceutical Bulletin 2004, 27:277-281.
7. Auger C., Mullen W., Hara Y., Crozier A. Bioavailability of polyphenon E flavan-3-ols in humans with an ileostomy. Journal of Nutrition 2008, 138:1535S-1542S.
8. Balentine D.A., Wiseman S.A., Bouwens L.C.M. The chemistry of tea flavonoids. CRC Reviews in Food Sciences and Nutrition 1997, 37:693-704.
9. Bancirova M. Comparison of the antioxidant capacity and the antimicrobial activity of black and green tea. Food Research International 2010, 43:1379-1382.
10. Bandyopadhyay D., Chatterjee T.K., Dasgupta A., Lourduraja J., Dastidar S.G. In vitro and in vivo antimicrobial action of tea: The commonest beverage of Asia. Biological & Pharmaceutical Bulletin 2005, 28:2125-2127.
11. Bansal D.D., Singla A., Boparai R. TeaóRole in health and diseases. Natural Product Radiance 2004, 3:156-166.
12. Bansal S., Syan N., Mathur P., Choudhary S. Pharmacological profile of green tea and its polyphenols: a review. Medicinal Chemistry Research 2011, 10.1007/s00044-011-9800-4.
13. Bruins M.J., Cermak R., Kiers J.L., Van D.M.J., Van A.J.M.M., Van K.B.J.W. In vivo and in vitro effects of tea extracts on enterotoxigenic Escherichia coli-induced intestinal fluid loss in animal models. Journal of Pediatric Gastroenterology and Nutrition 2006, 43:459-469.
14. Cabrera C., Gimenez R., Lopez C.M. Determination of tea components with antioxidant activity. Journal of Agricultural and Food Chemistry 2003, 51:4427-4435.
15. Cetojevic-Simin D.D., Bogdanovic G.M., Cvetkovic D.D., Velicanski A.S. Antiproliferative and antimicrobial activity of traditional Kombucha and Satureja montana L. Kombucha. Journal of Balkan Union of Oncology 2008, 13:395-401.
16. Chan E.W.C., Soh E.Y., Tie P.P., Law Y.P. Antioxidant and antibacterial properties of green, black, and herbal teas of Camellia sinensis. Pharmacognosy Research 2011, 3:266-272.
17. Chen Y.-L., Tsai H.-L., Peng C.-W. EGCG debilitates the persistence of EBV latency by reducing the DNA binding potency of nuclear antigen 1. Biochemical and Biophysical Research Communications 2012, 417:1093-1099.
18. Cho Y.-S., Oh J.-J., Oh K.-H. Antimicrobial activity and biofilm formation inhibition of green tea polyphenols on human teeth. Biotechnology and Bioprocess Engineering 2010, 15:359-364.
19. Cho Y.-S., Oh J.J., Oh K.-H. Synergistic anti-bacterial and proteomic effects of epigallocatechin gallate on clinical isolates of imipenem-resistant Klebsiella pneumonia. Phytomedicine 2011, 18:941-946.
20. Cho Y.S., Schiller N.L., Kahng H.Y., Oh K.H. Cellular responses and proteomic analysis of Escherichia coli exposed to green tea polyphenols. Current Microbiology 2007, 55:501-506.
21. Chow H.H., Cai Y., Alberts D.S., Hakim I., Dorr R., Shahi F., et al. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E. Cancer Epidemiology, Biomarkers & Prevention 2001, 10:53-58.
22. Cui Y., Oh Y.J., Lim J., Youn M., Lee I., Pak H.K., et al. AFM study of the differential inhibitory effects of the green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG) against gram-positive and gram-negative bacteria. Food Microbiology 2012, 29:80-87.
23. Daikoku T., Horiba K., Miyata K., Takemoto M., Okuda T., Yoshida Y., et al. Polyphenols including catechin from green tea with in vitro antiviral activity exhibited anti-herpes simplex virus activity but not anti-influenza virus activity in mice. Journal of Traditional Medicines 2011, 28:63-72.
24. Devine A., Hodqson J.M., Dick I.M., Prince R.L. Tea drinking is associated with benefits on bone density in older women. The American Journal of Clinical Nutrition 2007, 86:1243-1247.
25. Evensen N.A., Braun P.C. The effects of tea polyphenols on Candida albicans: Inhibition of biofilm formation and proteasome inactivation. Canadian Journal of Microbiology 2009, 55:1033-1039.
26. Ferrazzano G.F., Roberto L., Amato I., Cantile T., Sangianantoni G., Ingenito A. Antimicrobial properties of green tea extract against cariogenic microflora: an in vivo study. Journal of Medicinal Food 2011, 14:907-911.
27. Food and Agriculture Organization of the United Nations-Production FAOSTAT Available from:, (accessed on 25.07.2012). http://faostat.fao.org/DesktopDefault.aspx?PageID=567&lang=en#ancor.
28. Frei B., Higdon J.V. Antioxidant activity of tea polyphenols in vivo: evidence from animal studies. Journal of Nutrition 2003, 133:3275S-3284S.
29. Friedman M. Overview of antibacterial, antitoxin, antiviral, and antifungal activities of tea flavonoids and teas. Molecular Nutrition & Food Research 2007, 51:116-134.
30. Friedman M., Henika P.R., Levin C.E., Mandrell R.E., Kozukue N. Antimicrobial activities of tea catechins and theaflavins and tea extracts against Bacillus cereus. Journal of Food Protection 2006, 69:354-361.
31. Furukawa, S., Kawabe, H., Ohori, H., Mukai, T., & Matsumoto, M. (2005). Preventive or therapeutic composition containing glutathione and/or catechin for viral infectious disease. PCT International Application, WO 2005007640 A1 20050127.
32. Furuta T., Hirooka Y., Abe A., Sugata Y., Ueda M., Murakami K., et al. Concise synthesis of dideoxy-epigallocatechingallate (DO-EGCG) and evaluation of its anti-influenza virus activity. Bioorganic & Medicinal Chemistry Letters 2007, 17:3095-3098.
33. Gibbons S., Moser E., Kaatz G.W. Catechin gallates inhibit multidrug resistance (MDR) in Staphylococcus aureus. Planta Medica 2004, 70:1240-1242.
34. Hamilton-Miller J.M.T. Antimicrobial properties of tea (Camellia sinensis L.). Antimicrobial Agents and Chemotherapy 1995, 39:2375-2377.
35. Hamza A., Zhan C.-G. How can (-)-epigallocatechin gallate from green tea prevent HIV-1 infection? Mechanistic insights from computational modeling and the implication for rational design of anti-HIV-1 entry inhibitors. The Journal of Physical Chemistry. B 2006, 110:2910-2917.
36. Han Y. Synergic anticandidal effect of epigallocatechin-O-gallate combined with amphotericin B in a murine model of disseminated candidiasis and its anticandidal mechanism. Biological & Pharmaceutical Bulletin 2007, 30:1693-1696.
37. Hara-Kudo Y., Yamasaki A., Sasaki M., Okubo T., Minai Y., Haga M., et al. Antibacterial action on pathogenic bacterial spore by green tea catechins. Journal of the Science of Food and Agriculture 2005, 85:2354-2361.
38. Hassani A.S., Amirmozafari N., Ordouzadeh N., Hamdi K., Nazari R., Ghaemi A. Volatile components of Camellia sinensis inhibit growth and biofilm formation of oral streptococci in vitro. Pakistan Journal of Biological Sciences 2008, 11:1336-1341.
39. Hatano T., Tsugawa M., Kusuda M., Taniguchi S., Yoshida T., Shiota S., et al. Enhancement of antibacterial effects of epigallocatechin gallate, using ascorbic acid. Phytochemistry 2008, 69:3111-3116.
40. Hayatsu H., Inada N., Kakutani T., Arimoto S., Negishi T., Mori K., et al. Suppression of genotoxicity of carcinogens by epigallocatechin gallate. Preventive Medicine 1992, 21:370-376.
41. He W., Li L.-X., Liao Q.-J., Liu C.-L., Chen X.-L. Epigallocatechin gallate inhibits HBV DNA synthesis in a viral replication-inducible cell line. World Journal of Gastroenterology 2011, 17:1507-1514.
42. Hirasawa M., Takada K. Multiple effects of green tea catechin on the antifungal activity of antimycotics against Candida albicans. Journal of Antimicrobial Chemotherapy 2004, 53:225-229.
43. Hirasawa M., Takada K., Otake S. Inhibition of acid production in dental plaque bacteria by green tea catechins. Caries Research 2006, 40:265-270.
44. Hisano M., Yamaguchi K., Inoue Y., Ikeda Y., Iijima M., Adachi M., et al. Inhibitory effect of catechin against the superantigen staphylococcal enterotoxin B (SEB). Archives of Dermatological Research 2003, 295:183-189.
45. (accessed on 30.07.2012). http://www.statisticbrain.com/tea-drinking-statistics/.
46. (accessed on 31.07.2012). http://www.tea.co.uk/page.php?id=237.
47. Hu Y., Jia J., Qiao J., Ge C., Cao Z. Antimicrobial activity of pu-erh tea extracts in vitro and its effects on the preservation of cooled mutton. Journal of Food Safety 2010, 30:177-195.
48. Hua D., Peng Q., Huang Y., Yao F., Qian Y. The mechanism of synergistic antibacterial action between ECG/EGCG and β-lactam antibiotics against MRSA. Zhongguo Ganran Yu Hualiao Zazhi 2010, 10:123-126.
49. Hua D., Peng Q., Zeng X., Yao F., Qian Y. Antibacterial activity of green tea and its extracts against MRSA. Zhongguo Kangshengsu Zazhi 2010, 35:228-233.
50. Huang S.-H., Tang Y.-Z., Zhou X.-M., Xie G., Kurihara H., He Z.-H., et al. Study on anti-influenza virus effect of tea polyphenols in vitro and in vivo. Chaye Kexue 2010, 30:302-308.
51. Ikeda I., Imasato Y., Sasaki E., Nakayama M., Nagao H., Takeo T., et al. Tea catechins decrease micellar solubility and intestinal absorption of cholesterol in rats. Biochimica et Biophysica Acta 1992, 1127:141-146.
52. Isaacs C.E., Wen G.Y., Xu W., Jia J.H., Rohan L., Corbo C., et al. Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus. Antimicrobial Agents and Chemotherapy 2008, 52:962-970.
53. Isaacs C.E., Xu W., Merz G., Hillier S., Rohan L., Wen G.Y. Digallate dimers of (-)-epigallocatechin gallate inactivate herpes simplex virus. Antimicrobial Agents and Chemotherapy 2011, 55:5646-5653.
54. Jiang F., Chen W., Yi K., Wu Z., Si Y., Han W., et al. The evaluation of catechins that contain a galloyl moiety as potential HIV-1 integrase inhibitors. Clinical Immunology 2010, 137:347-356.
55. Jin E., Wu Y., Tu Y. Study on antibacterial effect of theaflavins. Zhongguo Shipin Xuebao 2011, 11:108-112.
56. Juneja V.K., Bari M.L., Inatsu Y., Kawamoto S., Friedman M. Control of Clostridium perfringens spores by green tea leaf extracts during cooling of cooked ground beef, chicken, and pork. Journal of Food Protection 2007, 70:1429-1433.
57. Kaihatsu K., Mori S., Matsumura H., Daidoji T., Kawakami C., Kurata H., et al. Broad and potent anti-influenza virus spectrum of epigallocatechin-3-O-gallate-monopalmitate. Journal of Molecular and Genetic Medicine 2009, 3:195-197.
58. Karori S.M., Wachira F.N., Wanyoko J.K., Ngure R.M. Antioxidant capacity of different types of tea products. African Journal of Biotechnology 2007, 6:2287-2296.
59. Kawai K., Tsuno N.H., Kitayama J., Okaji Y., Yazawa K., Asakage M., et al. Epigallocatechin gallate, the main component of tea polyphenol, binds to CD4 and interferes with gp120 binding. The Journal of Allergy and Clinical Immunology 2003, 112:951-957.
60. Kim Y.J., Houng S.-J., Kim J.H., Kim Y.-R., Ji H.G., Lee S.-J. Nanoemulsified green tea extract shows improved hypocholesterolemic effects in C57BL/6 mice. The Journal of Nutritional Biochemistry 2012, 23:186-191.
61. Kim J.-S., Kim Y. The inhibitory effect of natural bioactives on the growth of pathogenic bacteria. Nutrition Research and Practice 2007, 1:273-278.
62. Kiran S., Ratho R.K., Sharma P., Harjai K., Capalash N., Tiwari R.P. Effect of black tea (Camellia sinensis) on virulence traits of clinical isolates of Shigella dysenteriae and Escherichia coli EPEC P2 1265 strain. European Food Research and Technology 2010, 231:763-770.
63. Klaus S., Pultz S., Thone-Reineke C., Wolfram S. Epigallocatechin gallate attenuates diet-induced obesity in mice by decreasing energy absorption and increasing fat oxidation. International Journal of Obesity 2005, 29:615-623.
64. Klugman K.P., Koornhof H.J. Worldwide increase in pneumococcal antibiotic resistance. Lancet 1989, 2:444.
65. Kobayashi N., Nishikawa T., Okayasu T., Yamada R., Isogai E., Isogai H., et al. Inhibitory effects of catechin-containing drinks on the growth of Salmonella enteritidis. Shikoku Igaku Zasshi 2006, 62:43-48.
66. Kohda C., Yanagawa Y., Shimamura T. Epigallocatechin gallate inhibits intracellular survival of Listeria monocytogenes in macrophages. Biochemical and Biophysical Research Communications 2008, 365:310-315.
67. Kumudavally K.V., Phanindrakumar H.S., Tabassum A., Radhakrishna K., Bawa A.S. Green tea - A potential preservative for extending the shelf life of fresh mutton at ambient temperature (25±2°C). Food Chemistry 2008, 107:426-433.
68. Lee Y.S., Han C.H., Kang S.H., Lee S.J., Kim S.W., Shin O.R., et al. Synergistic effect between catechin and ciprofloxacin on chronic bacterial prostatitis rat model. International Journal of Urology 2005, 12:383-389.
69. Lee K.-M., Kim W.-S., Lim J., Nam S., Youn M., Nam S.-W., et al. Antipathogenic properties of green tea polyphenol epigallocatechin gallate at concentrations below the MIC against enterohemorrhagic Escherichia coli O157:H7. Journal of Food Protection 2009, 72:325-331.
70. Lee M.J., Maliakal P., Chen L., Meng X., Bondoc F.Y., Prabhu S., et al. Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. Cancer Epidemiology, Biomarkers & Prevention 2002, 11:1025-1032.
71. Lee K.-M., Yeo M., Choue J.-S., Jin J.-H., Park S.J., Cheong J.-Y., et al. Protective mechanism of epigallocatechin-3-gallate against Helicobacter pylori-induced gastric epithelial cytotoxicity via the blockage of TLR-4 signaling. Helicobacter 2004, 9:632-642.
72. Li S., Hattori T., Kodama E.N. Epigallocatechin gallate inhibits the HIV reverse transcription step. Antiviral Chemistry & Chemotherapy 2011, 21:239-243.
73. Li J., Zhou L., Zhang Y. Studies on the effects of tea catechins against hepatitis B virus infection. Zhonghua Yu Fang Yi Xue Za Zhi 2001, 35:404-407.
74. Lin J.-K., Lin C.-L., Liang Y.-C., Lin-Shiau S.-Y., Juan I.-M. Survey of catechins, gallic acid, and methylxanthines in green, oolong, pu-erh, and black teas. Journal of Agricultural and Food Chemistry 1998, 46:3635-3642.
75. Liu S., Lu H., Zhao Q., He Y., Niu J., Debnath A.K., et al. Theaflavin derivatives in black tea and catechin derivatives in green tea inhibit HIV-1 entry by targeting gp41. Biochimica et Biophysica Acta, General Subjects 2005, 1723:270-281.
76. Liu Q., Wang Y., Xu P., Zhang H., Zhao Y., Lu Y. Antibacterial activity of catechins against heterogeneous vancomycin resistant Staphylococcus. Zhongguo Kangshengsu Zazhi 2011, 36:557-560.
77. Matsumoto Y., Kaihatsu K., Nishino K., Ogawa M., Kato N., Yamaguchi A. Antibacterial and antifungal activities of new acylated derivatives of epigallocatechin gallate. Frontiers in Microbiology 2012, 3(53):1-10.
78. Matsumoto M., Mukai T., Furukawa S., Ohori H. Inhibitory effects of epigallocatechin gallate on the propagation of bovine coronavirus in Madin-Darby bovine kidney cells. Animal Science Journal 2005, 76:507-512.
79. Matsumura, K., Okazaki, S., Xuan, C. X., Komasa, H., & Sugai, H. (2009). Epigallocatechin gallate from green tea polyphenol and ε-poly-l-lysine as antifungal oral cavity care compositions. Japanese Kokai Tokkyo Koho, JP 2009269899 A 20091119.
80. Matsuura, K., Ogawa, H., Goto, K., & Hara, M. (2007). Tea catechins and caffeine as antifungal agents against tiena. Japanese Kokai Tokkyo Koho, JP 2007176884 A 20070712.
81. Meng X., Sang S., Zhu N., Lu H., Sheng S., Lee M.J., et al. Identification and characterization of methylated and ring-fission metabolites of tea catechins formed in humans, mice, and rats. Chemical Research in Toxicology 2002, 15:1042-1050.
82. Min Z., Peigen X. Quantitative analysis of the active constituents in green tea. Phytotherapy Research 1991, 5:239-240.
83. Miyamoto T., Nakayama M., Shigemune N., Tokuda H., Matsushita T., Furuta K., et al. Application of green tea extract as food preservative to improve shelf life of overnight pickled cucumber. Nippon Shokuhin Kagaku Kogaku Kaishi 2009, 56:660-664.
84. Mo H., Zhu Y., Chen Z. Microbial fermented tea - A potential source of natural food preservatives. Trends in Food Science & Technology 2008, 19:124-130.
85. Mori S., Miyake S., Kobe T., Nakaya T., Fuller S.D., Kato N., et al. Enhanced anti-influenza A virus activity of (-)-epigallocatechin-3-O-gallate fatty acid monoester derivatives: Effect of alkyl chain length. Bioorganic & Medicinal Chemistry Letters 2008, 18:4249-4252.
86. Mukamal K.J., Maclure M., Muller J.E., Sherwood J.B., Mittleman M.A. Tea consumption and mortality after acute myocardial infarction. Circulation 2002, 105:2476-2481.
87. Naderi N.J., Niakan M., Kharazi F.M.J., Zardi S. Antibacterial activity of Iranian green and black tea on Streptococcus mutans: an in vitro study. Journal of Dentistry 2011, 8:55-59.
88. Nakayama M., Shigemune N., Tokuda H., Furuta K., Matsushita T., Yoshizawa C., et al. Combined effects of surfactants and preservatives on the antibacterial activity of green tea extracts. Bokin Bobai 2009, 37:169-179.
89. Nakayama M., Shigemune N., Tsugukuni T., Jun H., Matsushita T., Mekada Y., et al. Mechanism of the combined anti-bacterial effect of green tea extract and NaCl against Staphylococcus aureus and Escherichia coli O157:H7. Food Control 2012, 25:225-232.
90. Nakayama M., Shigemune N., Tsugukuni T., Tokuda H., Miyamoto T. Difference of EGCG adhesion on cell surface between Staphylococcus aureus and Escherichia coli visualized by electron microscopy after novel indirect staining with cerium chloride. Journal of Microbiological Methods 2011, 86:97-103.
91. Nakayama M., Suzuki K., Toda M., Okubo S., Hara Y., Shimamura T. Inhibition of the infectivity of the influenza virus by tea polyphenols. Antiviral Resistance 1993, 21:289-299.
92. Natsume M., Osakabe N., Oyama M., Sasaki M., Baba S., Nakamura Y., et al. Structures of (-)-epicatechin glucuronide identified from plasma and urine after oral ingestion of (-)-epicatechin: differences between human and rat. Free Radical Biology & Medicine 2003, 34:840-849.
93. Navarro-Martinez M.D., Garcia-Canovas F., Rodriguez-Lopez J.N. Tea polyphenol epigallocatechin-3-gallate inhibits ergosterol synthesis by disturbing folic acid metabolism in Candida albicans. Journal of Antimicrobial Chemotherapy 2006, 57:1083-1092.
94. Neyestani T.R., Khalaji N., Gharavi A. Selective microbiologic effects of tea extract on certain antibiotics against Escherichia coli in vitro. Journal of Alternative and Complementary Medicine 2007, 13:1119-1124.
95. Nie, J. (2010). Preparation of pharmaceutical formulations containing epigallocatechin-3-O-gallate and/or epicatechin-3-O-gallate for nasal inhalation drug delivery for treating common cold and influenza. Faming Zhuanli Shenqing, CN 101816645 A 20100901.
96. Ojo O.A., Yunusa A.O., Akindele S.K., Vera V.N., Fowora N. The antimicrobial activities of processed Nigerian and South African black tea. African Journal of Medicine and Medical Sciences 2010, 39:145-151.
97. Ooshima T. Anti-caries activity of tea polyphenols. Foods & Food Ingredients Journal of Japan 2005, 210:325-330.
98. Osterburg A., Gardner J., Hyon S.H., Neely A., Babcock G. Highly antibiotic-resistant Acinetobacter baumannii clinical isolates are killed by the green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG). Clinical Microbiology and Infection 2009, 15:341-346.
99. Otsuka T., Ogo T., Eto T., Asano Y., Suganuma M., Niho Y. Growth inhibition of leukemic cells by (-)-epigallocatechin gallate, the main constituent of green tea. Life Sciences 1998, 63:1397-1403.
100. Park B.J., Park J.-C., Taguchi H., Fukushima K., Hyon S.-H., Takatori K. Antifungal susceptibility of epigallocatechin 3-O-gallate on clinical isolates of pathogenic yeasts. Biochemical and Biophysical Research Communications 2006, 347:401-405.
101. Park B.J., Taguchi H., Kamei K., Matsuzawa T., Hyon S.-H., Park J.-C. In vitro antifungal activity of epigallocatechin-3-O-gallate against clinical isolates of dermatophytes. Yonsei Medical Journal 2011, 52:535-538.
102. Patar A., Nishikawa K., Tanaka N., Ishimaru K., Maeda H. Antibacterial activities of extracts and constituents in the complex of tea catechins and soybean protein. Nippon Shokuhin Kagaku Gakkaishi 2003, 10:161-164.
103. Pei S., Zhang Y., Xu H., Chen X., Chen S. Inhibition of the replication of hepatitis B Virus in vitro by pu-erh tea extracts. Journal of Agricultural and Food Chemistry 2011, 59:9927-9934.
104. Perumalla A.V.S., Hettiarachchy N.S. Green tea and grape seed extracts - Potential applications in food safety and quality. Food Research International 2011, 44:827-839.
105. Peterson J., Dwyera J., Bhagwat S., Haytowitz D., Holden J., Eldridge A.L., et al. Major flavonoids in dry tea. Journal of Food Composition and Analysis 2005, 18:487-501.
106. Pisters K.M., Newman R.A., Coldman B., Shin D.M., Khuri F.R., Hong W.K., et al. Phase I trial of oral green tea extract in adult patients with solid tumors. Journal of Clinical Oncology 2001, 19:1830-1838.
107. Podlipnik C. Docking of selected natural polyphenols to ARF activated A1 subunit of cholera toxin. Acta Chimica Slovenica 2009, 56:156-165.
108. Ramassamy C. Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: a review of their intracellular targets. European Journal of Pharmacology 2006, 545:51-64.
109. Roccaro A.S., Blanco A.R., Giuliano F., Rusciano D., Enea V. Epigallocatechin-gallate enhances the activity of tetracycline in staphylococci by inhibiting its efflux from bacterial cells. Antimicrobial Agents and Chemotherapy 2004, 48:1968-1973.
110. Rogers J., Perkins I., Van O.A., Burdash N., Klein T.W., Friedman H. Epigallocatechin gallate modulates cytokine production by bone marrow-derived dendritic cells stimulated with lipopolysaccharide or muramyldipeptide, or infected with Legionella pneumophila. Experimental Biology and Medicine 2005, 230:645-651.
111. Sakagami H., Asano K., Hara Y., Shinamura T. Stimulation of human monocyte and polymorphonuclear cell iodination and interleukin-1 production by epigallocatechin gallate. Journal of Leukocyte Biology 1992, 51:478-483.
112. Sari F., Turkmen N., Polat G., Velioglu Y.S. Total polyphenol, antioxidant and antibacterial activities of black mate tea. Food Science and Technology Research 2007, 13:265-269.
113. Sasaki H., Matsumoto M., Tanaka T., Maeda M., Nakai M., Hamada S., et al. Antibacterial activity of polyphenol components in oolong tea extract against Streptococcus mutans. Caries Research 2004, 38:2-8.
114. Sato D. Inhibition of urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine in rats by green tea. International Journal of Urology 1999, 6:93-99.
115. Savi L.A., Barardi C.R.M., Simoes C.M.O. Evaluation of antiherpetic activity and genotoxic effects of tea catechin derivatives. Journal of Agricultural and Food Chemistry 2006, 54:2552-2557.
116. Scalbert A., Manach C., Morand C., Rémésy C. Dietary polyphenols and the prevention of diseases. Critical Reviews in Food Science and Nutrition 2005, 45:287-306.
117. Sharma S.K., Kumar G., Kapoor M., Surolia A. Combined effect of epigallocatechin gallate and triclosan on enoyl-ACP reductase of Mycobacterium tuberculosis. Biochemical and Biophysical Research Communications 2008, 368:12-17.
118. Shigemune N., Nakayama M., Tsugukuni T., Hitomi J., Yoshizawa C., Mekada Y., et al. The mechanisms and effect of epigallocatechin gallate (EGCG) on the germination and proliferation of bacterial spores. Food Control 2012, 27:269-274.
119. Shimamura T., Zhao W.-H., Hu Z.-Q. Mechanism of action and potential for use of tea catechin as an antiinfective agent. Anti-Infective Agents in Medicinal Chemistry 2007, 6:57-62.
120. Shin J.-S., Chung H.-S. Antibacterial activities of phenolic components from Camellia sinensis L. on pathogenic microorganisms. Journal of Food Sciences and Nutrition 2007, 12:135-140.
121. Shoji Y., Nakashima H. Glucose-lowering effect of powder formulation of African black tea extract in KK-A(y)/TaJcl diabetic mouse. Archives of Pharmacal Research 2006, 29:786-794.
122. Si W., Gong J., Tsao R., Kalab M., Yang R., Yin Y. Bioassay-guided purification and identification of antimicrobial components in Chinese green tea extract. Journal of Chromatography. A 2006, 1125:204-210.
123. Sitheeque M.A.M., Panagoda G.J., Yau J., Amarakoon A.M.T., Udagama U.R.N., Samaranayake L.P. Antifungal activity of black tea polyphenols (catechins and theaflavins) against Candida species. Chemotherapy 2009, 55:189-196.
124. Song J.M., Park K.D., Lee K.H., Byun Y.H., Park J.H., Kim S.H., et al. Biological evaluation of anti-influenza viral activity of semi-synthetic catechin derivatives. Antiviral Research 2007, 76:178-185.
125. Stanczyk A., Skolimowska U., Wedzisz A. Contents of tannins in green and black teas and antibactericidal activity of methanolic extracts. Bromatologia i Chemia Toksykologiczna 2008, 41:976-980.
126. Stapleton P.D., Shah S., Hara Y., Taylor P.W. Potentiation of catechin gallate-mediated sensitization of Staphylococcus aureus to oxacillin by nongalloylated catechins. Antimicrobial Agents and Chemotherapy 2006, 50:752-755.
127. Staszewski M.V., Pilosof A.M.R., Jagus R.J. Antioxidant and antimicrobial performance of different argentinean green tea varieties as affected by whey proteins. Food Chemistry 2011, 125:186-192.
128. Stoicov C., Saffari R., Houghton J. Green tea inhibits Helicobacter growth in vivo and in vitro. International Journal of Antimicrobial Agents 2009, 33:473-478.
129. Su Y., Zhang C., Wang Y., Li P. Antibacterial property and mechanism of a novel pu-erh tea nanofibrous membrane. Applied Microbiology and Biotechnology 2012, 93:1663-1671.
130. Sugai, H., Park, J. C., Han, D. W., & Hyeon, S. G. (2008). Topical antifungal compositions containing polyphenol. Japanese Kokai Tokkyo Koho, JP 2008007464 A 20080117.
131. Surh, Y. J., Kang, D. K., Lee, J. S., & Park, C. S. (2006). Green tea extract comprising polyphenol ingredient of green tea having antibacterial activity of Helicobacter pylori and inhibitory effect to urease activity and health food using the same. Republic Korean Kongkae Taeho Kongbo, KR 2006122439 A 20061130.
132. Tadakatsu S., Wei-Hua Z., Zhi-Qing H. Mechanism of action and potential for use of tea catechin as an antiinfective agent. Anti-Infective Agents in Medicinal Chemistry 2007, 6:57-62.
133. Tan W., Shi L., Zhu W., Tan J. Effect of anti-influenza virus of EGCG. Zhongguo Yiyuan Yaoxue Zazhi 2009, 29:376-378.
134. Taylor P.W., Stapleton P.D., Luzio J.P. New ways to treat bacterial infections. Drug Discovery Today 2002, 7:1086-1091.
135. Turchetti B., Pinelli P., Buzzini P., Romani A., Heimler D., Franconi F., et al. In vitro antimycotic activity of some plant extracts towards yeast and yeast-like strains. Phytotherapy Research 2005, 19:44-49.
136. Turkmen N., Velioglu Y.S., Sari F., Polat G. Effect of extraction conditions on measured total polyphenol contents and antioxidant and antibacterial activities of black tea. Molecules 2007, 12:484-496.
137. Uchida S., Ozaki M., Suzuki K., Shikita M. Radioprotective effects of epigallocatechin 3-O-gallate (green tea tannin) in mice. Life Sciences 1992, 50:147-152.
138. USDA Database for the flavonoid content of selected foods release 2.1 Available from:, (accessed on 02.08.2012). http://www.nal.usda.gov/fnic/foodcomp/Data/Flav/Flav02-1.pdf.
139. Van A.J.M., Van H.K.H., Mathot J.N., Mulder T.P., Wiersma A., Tijburg L.B. Plasma concentrations of individual tea catechins after a single oral dose in humans. Xenobiotica 2001, 31:891-901.
140. Wang, H., Xu, J., Deng, F., & Hu, Z. (2007). Natural extract of green tea for inhibiting hepatitis B virus and its primary active ingredient. Faming Zhuanli Shenqing, CN 101028382 A 20070905.
141. Weber J.M., Ruzindana-Umunyana A., Imbeault L., Sircar S. Inhibition of adenovirus infection and adenain by green tea catechins. Antiviral Research 2003, 58:167-173.
142. Williamson M.P., McCormick T.G., Nance C.L., Shearer W.T. Epigallocatechin gallate, the main polyphenol in green tea, binds to the T-cell receptor, CD4: potential for HIV-1 therapy. The Journal of Allergy and Clinical Immunology 2006, 118:1369-1374.
143. Wu S.-C., Yen G.-C., Wang Z.-S., Chiu C.-K., Yen W.-J., Chang L.-W., et al. Antimutagenic and antimicrobial activities of pu-erh tea. LWT-Food Science and Technology 2007, 40:506-512.
144. Xiao X., Yang Z., Shi L., Liu J., Chen W. Study on anti-influenza virus effects of epigallocatechingallate. Zhongguo Zhongyao Zazhi 2008, 33:2678-2681.
145. Xu B., Liu Z., Ren F., Sun Y. Effects of natural preservative and modified atmosphere packaging on shelf-life of sliced beef ham. Nongye Gongcheng Xuebao 2006, 22:143-147.
146. Xu J., Wang J., Deng F., Hu Z., Wang H. Green tea extract and its major component epigallocatechin gallate inhibits hepatitis B virus in vitro. Antiviral Research 2008, 78:242-249.
147. Xu X., Zhou X.D., Wu C.D. The tea catechin epigallocatechin gallate suppresses cariogenic virulence factors of Streptococcus mutans. Antimicrobial Agents and Chemotherapy 2011, 55:1229-1236.
148. Xu X., Zhou X.D., Wu C.D. Tea catechin epigallocatechin gallate inhibits Streptococcus mutans biofilm formation by suppressing gtf genes. Archives of Oral Biology 2012, 57:678-683.
149. Yamamoto Y., Matsunaga K., Friedman H. Protective effects of green tea catechins on alveolar macrophages against bacterial infections. BioFactors 2004, 21:119-121.
150. Yang C.S., Chen L., Lee M.J. Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers. Cancer Epidemiology, Biomarkers & Prevention 1998, 7:351-354.
151. Yang J., Li R.-M., Mao Q.-C., Chen Z.-P., Jiang S.-B., Jiang Z.-H., et al. HIV fusion-inhibiting activity of peracetate ester of (-)-epigallocatechin gallate and the mechanism. Zhongguo Xinyao Zazhi 2010, 19:1967-1972.
152. Yang J., Li L., Tan S., Jin H., Qiu J., Mao Q., et al. A natural theaflavins preparation inhibits HIV-1 infection by targeting the entry step: Potential applications for preventing HIV-1 infection. Fitoterapia 2012, 83:348-355.
153. Yang L., Liu Y., Sternberg C., Molin S. Evaluation of enoyl-acyl carrier protein reductase inhibitors as Pseudomonas aeruginosa quorum-quenching reagents. Molecules 2010, 15:780-792.
154. Yang, Z. & Shi, L. (2007). Application of plant extract catechins in preparing antiviral drugs. Faming Zhuanli Shenqing, CN 1994294 A 20070711.
155. Yi S., Li J., Zhu J., Lin Yi, Fu L., Chen W., et al. Effect of tea polyphenols on microbiological and biochemical quality of Collichthys fish ball. Journal of the Science of Food and Agriculture 2011, 91:1591-1597.
156. Yoda Y., Hu Z.-Q., Zhao W.-H., Shimamura T. Different susceptibilities of Staphylococcus and gram-negative rods to epigallocatechin gallate. Journal of Infection and Chemotherapy 2004, 10:55-58.
157. Zhao W.-H., Hu Z.-Q., Okubo S., Hara Y., Shimamura T. Mechanism of synergy between epigallocatechin gallate and β-lactams against methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 2001, 45:1737-1742.
158. Zhao Y., Wang H., Zhao X.-R., Luo F.-J., Tang M., Cao Y. Epigallocatechin-3-gallate interferes with EBV-encoding AP-1 signal transduction pathway. Zhonghua Zhong Liu Za Zhi 2004, 26:393-397.
159. Zhong Y., Ma C.-M., Shahidi F. Antioxidant and antiviral activities of lipophilic epigallocatechin gallate (EGCG) derivatives. Journal of Functional Foods 2012, 4:87-93.
160. Zhou W.-W., Zhang L.-X., Zhang B., Wang F., Liang Z.-H., Niu T.-G. Isolation and characterization of ZH14 with antiviral activity against tobacco mosaic virus. Canadian Journal of Microbiology 2008, 54:441-449.
161. Zu M., Yang F., Zhou W., Liu A., Du G., Zheng L. In vitro anti-influenza virus and anti-inflammatory activities of theaflavin derivatives. Antiviral Research 2012, 94:217-224.